专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2009058244A1 PROTECTIVE SKIN CARE TETRAPEPTIDES 审中-公开
标题翻译：保护性皮肤护理品
公开(公告)号：WO2009058244A1
公开(公告)日：2009-05-07
申请号：PCT/US2008/012191
申请日：2008-10-28
申请人： HELIX BIOMEDIX INC. , ZHANG, Lijuan , HARRIS, Scott, M. , FALLA, Timothy, J.
发明人： ZHANG, Lijuan , HARRIS, Scott, M. , FALLA, Timothy, J.
IPC分类号： C07K5/10
CPC分类号： C07K5/1024 , A61K8/64 , A61K38/00 , A61K2800/782 , A61Q19/08
摘要： The disclosed invention provides tetrapeptides with the amino acid sequence proline- glutamine-glutamate-X (P-Q-E-X), where X can be either lysine (K) or isoleucine (I). These tetrapeptides inhibit ultraviolet light (UV)-induced expression of the pro-inflammatory cytokine interleukin-6 (IL-6) by skin epithelial cells and fibroblasts. Furthermore, the tetrapeptides repress the upregulation of matrix metalloproteinase-1 (MMP-1) by skin fibroblasts induced by either direct exposure to UV rays or treatment with media conditioned by UV-treated keratinocytes. The small size and bio-activity of the tetrapeptides render them suitable for use in therapies directed to inflammatory skin disorders and as active ingredients in skin care products.
摘要翻译：所公开的发明提供四肽与氨基酸序列脯氨酸 - 谷氨酰胺 - 谷氨酸酯-X（P-Q-E-X），其中X可以是赖氨酸（K）或异亮氨酸（I）。这些四肽通过皮肤上皮细胞和成纤维细胞抑制紫外线（UV）诱导的促炎细胞因子白细胞介素-6（IL-6）的表达。此外，四肽通过直接暴露于紫外线诱导的皮肤成纤维细胞抑制基质金属蛋白酶-1（MMP-1）的上调或通过经紫外线处理的角质形成细胞调节的培养基来治疗。四肽的小尺寸和生物活性使其适合用于治疗炎症性皮肤病症和作为皮肤护理产品中的活性成分。

2. 发明申请

WO2007146269A3 PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS 审中-公开
标题翻译：诱导细胞基质蛋白合成的肽片段
公开(公告)号：WO2007146269A3
公开(公告)日：2008-08-14
申请号：PCT/US2007013748
申请日：2007-06-12
申请人： HELIX BIOMEDIX INC , HARRIS SCOTT M , FALLA TIMOTHY J , ZHANG LIJUAN
发明人： HARRIS SCOTT M , FALLA TIMOTHY J , ZHANG LIJUAN
IPC分类号： C07K14/78 , C07K5/10
CPC分类号： A61K38/07 , A61K8/64 , A61K9/0014 , A61K9/06 , A61K38/00 , A61K2121/00 , A61K2300/00 , A61Q19/00 , A61Q19/08 , C07K5/1002 , C07K5/1008 , C07K5/1024 , C07K14/78
摘要： [0049] Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x is a variable amino acid. The peptides can be used singly or in combination to stimulate production of extracellular matrix proteins in skin. A rapid, low-cost method of producing heterogenous formulations of tetrapeptides is disclosed.
摘要翻译：公开了由保持G（甘氨酸）和P（脯氨酸）并且x是可变氨基酸的序列GxxG和PxxP组成的短生物活性四肽。肽可单独使用或组合使用以刺激皮肤中细胞外基质蛋白的产生。公开了生产四肽的异源制剂的快速，低成本的方法。

3. 发明申请

WO1998017267A1 COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS 审中-公开
标题翻译：用于治疗骨质疏松症状的组合物和方法
公开(公告)号：WO1998017267A1
公开(公告)日：1998-04-30
申请号：PCT/US1997018864
申请日：1997-10-23
申请人： ZYMOGENETICS, INC. , OSTEOSCREEN, INC. , UNIVERSITY OF TEXAS AUSTIN , ORME, Mark, W. , BAINDUR, Nand , ROBBINS, Kirk, G. , HARRIS, Scott, M. , KONTOYIANNI, Maria , HURLEY, Laurence, H. , KERWIN, Sean, M. , MUNDY, Gregory, R. , PETRIE, Charles
发明人： ZYMOGENETICS, INC. , OSTEOSCREEN, INC. , UNIVERSITY OF TEXAS AUSTIN
IPC分类号： A61K31/165
CPC分类号： A61K31/655 , A61K31/196 , A61K31/4184 , A61K31/428 , A61K31/444 , A61K31/47 , A61K31/4709 , A61K31/498 , A61K31/517 , A61K31/53
摘要： Compounds containing two aromatic systems covalently linked through a linker containing one or more atoms, or "linker" defined as including a covalent bond per se so as to space the aromatic systems at a distance 1.5-15 ANGSTROM , are effective in treating conditions associated with bone deficits. The compounds can be administered to vertebrate subjects alone or in combination with additional agents that promote bone growth or that inhibit bone resorption. They can be screened for activity prior to administration by assessing their ability to effect the transcription of a reporter gene coupled to a promoter associated with a bone morphogenetic protein and/or their ability to stimulate calvarial growth in model animal systems.
摘要翻译：包含通过含有一个或多个原子的接头共价连接的两个芳族体系的化合物或定义为包含共价键本身的“连接体”，以使芳族体系在距离为1.5-15安培的范围内空间有效地处理与骨缺损。化合物可以单独施用于脊椎动物，或者与促进骨生长或抑制骨吸收的其它试剂组合施用。可以通过评估其在影响与骨形态发生蛋白相关的启动子相关的报告基因的转录和/或刺激模型动物系统中颅骨生长的能力的能力来筛选其给药前的活性。

4. 发明申请

WO2006086321A3 ANTIMICROBIAL HEXAPEPTIDES 审中-公开
标题翻译：抗生素下一代
公开(公告)号：WO2006086321A3
公开(公告)日：2007-02-22
申请号：PCT/US2006004147
申请日：2006-02-07
申请人： HELIX BIOMEDIX INC , FALLA TIMOTHY J , ZHANG LIJUAN , HARRIS SCOTT M
发明人： FALLA TIMOTHY J , ZHANG LIJUAN , HARRIS SCOTT M
IPC分类号： C07K7/06 , A61K38/08 , A61P31/00
CPC分类号： C07K7/06 , A61K38/00
摘要： The invention encompasses hexapeptides consisting of alternating hydrophobic residues (B) at positions 2, 4, and 6, hydrophilic, hydrophilic, charged residues (X) at positions 1 and 3, and a naphthylalanine (NaI), an aliphatic or aromatic residue (O) at position five, represented generally by the formula XBXBOB, which exhibit antimicrobial activity against infections caused by a variety of pathogens. These pathogens may include gram positive or negative bacteria, acid-fast bacteria such a mycobacteria, parasites, dermatophytes, or fungal pathogens. Typical fungal pathogens include Candida albicans and typical dermatophytes include Trichophyton rubrum and Trichophyton mentagrophytes. The hexapeptides of the present invention exhibit antifungal activity, antibacterial activity, desirable stability, and lack toxicity to the mammal receiving treatment.
摘要翻译：本发明包括由位置2,4和6处的交替的疏水性残基（B），位置1和3的亲水性，亲水性，带电荷的残基（X）和萘丙氨酸（NaI），脂族或芳族残基（O ），通常由式XBXBOB表示，其表现出针对由各种病原体引起的感染的抗微生物活性。这些病原体可包括革兰氏阳性或阴性细菌，耐酸细菌如分枝杆菌，寄生虫，皮肤真菌或真菌病原体。典型的真菌病原体包括白色念珠菌和典型的皮肤癣菌，包括红色毛癣菌和引发毛癣菌。本发明的六肽对接受治疗的哺乳动物具有抗真菌活性，抗菌活性，所需的稳定性和缺乏毒性。

5. 发明申请

WO2008085494A1 SHORT BIO-ACTIVE PEPTIDES FOR CELLULAR AND IMMUNOLOGICAL MODULATION 审中-公开
标题翻译：短生物活性肽细胞和免疫调节
公开(公告)号：WO2008085494A1
公开(公告)日：2008-07-17
申请号：PCT/US2007/026368
申请日：2007-12-27
申请人： HELIX BIOMEDIX INC. , HARRIS, Scott, M. , ZHANG, Lijuan , FALLA, Timothy, J.
发明人： HARRIS, Scott, M. , ZHANG, Lijuan , FALLA, Timothy, J.
IPC分类号： C07K14/435 , A61K38/00
CPC分类号： C07K14/43563 , A61K38/00 , C07K5/1024 , C07K7/08
摘要： Peptides having four to fourteen residues are disclosed that possess biological activity. These peptides constitute short fragments of the peptide HB-107 (SEQ ID NO:1), which itself is a fragment of the antimicrobial protein cecropin B, and exhibit cell stimulatory, migratory and anti-inflammatory properties. As keratinocytes are especially sensitive to these effects, the disclosed peptides comprise a useful agent for the medical treatment of injury to the skin, such as from diabetic ulcers. The peptides also are effective in preventing and reversing skin surface damage resulting from various environmental insults. Importantly, the therapeutic effects of the peptides manifest at concentrations equal to or greater than those of peptide HB-107, and thus represent a less expensive, more versatile means for developing effective therapies. Methods for the production and use of these peptides are also disclosed.
摘要翻译：披露具有四至十四个残基的肽具有生物活性。这些肽构成肽HB-107（SEQ ID NO：1）的短片段，其本身是抗微生物蛋白质天蚕素B的片段，并且具有细胞刺激性，迁移性和抗炎性质。由于角质形成细胞对这些作用特别敏感，所公开的肽包括用于治疗皮肤损伤（例如糖尿病性溃疡）的有用试剂。这些肽也有效地预防和逆转由各种环境污染引起的皮肤表面损伤。重要的是，肽的治疗效果以等于或大于肽HB-107的浓度表现，因此代表开发有效疗法的较便宜，更通用的手段。还公开了生产和使用这些肽的方法。

6. 发明申请

WO2007146269A2 PEPTIDE FRAGMENTS FOR INDUCING SYNTHESIS OF EXTRACELLULAR MATRIX PROTEINS 审中-公开
标题翻译：诱导细胞基质蛋白合成的肽片段
公开(公告)号：WO2007146269A2
公开(公告)日：2007-12-21
申请号：PCT/US2007/013748
申请日：2007-06-12
申请人： HELIX BIOMEDIX INC. , HARRIS, Scott, M. , FALLA, Timothy, J. , ZHANG, Lijuan
发明人： HARRIS, Scott, M. , FALLA, Timothy, J. , ZHANG, Lijuan
IPC分类号： C07K14/78 , C07K5/10
CPC分类号： A61K38/07 , A61K8/64 , A61K9/0014 , A61K9/06 , A61K38/00 , A61K2121/00 , A61K2300/00 , A61Q19/00 , A61Q19/08 , C07K5/1002 , C07K5/1008 , C07K5/1024 , C07K14/78
摘要： [0049] Short biologically active tetrapeptides are disclosed that are comprised of the sequences GxxG and PxxP where G (glycine) and P (proline) are maintained and x is a variable amino acid. The peptides can be used singly or in combination to stimulate production of extracellular matrix proteins in skin. A rapid, low-cost method of producing heterogenous formulations of tetrapeptides is disclosed.
摘要翻译：公开了由保持G（甘氨酸）和P（脯氨酸）并且x是可变氨基酸的序列GxxG和PxxP组成的短生物活性四肽。肽可单独使用或组合使用以刺激皮肤中细胞外基质蛋白的产生。公开了生产四肽的异源制剂的快速，低成本的方法。

7. 发明申请

WO2006086321A2 ANTIMICROBIAL HEXAPEPTIDES 审中-公开
标题翻译：抗生素下一代
公开(公告)号：WO2006086321A2
公开(公告)日：2006-08-17
申请号：PCT/US2006/004147
申请日：2006-02-07
申请人： HELIX BIOMEDIX INC. , FALLA, Timothy, J. , ZHANG, Lijuan , HARRIS, Scott, M.
发明人： FALLA, Timothy, J. , ZHANG, Lijuan , HARRIS, Scott, M.
CPC分类号： C07K7/06 , A61K38/00 , Y02A50/473
摘要： The invention encompasses hexapeptides consisting of alternating hydrophobic residues (B) at positions 2, 4, and 6, hydrophilic, hydrophilic, charged residues (X) at positions 1 and 3, and a naphthylalanine (NaI), an aliphatic or aromatic residue (O) at position five, represented generally by the formula XBXBOB, which exhibit antimicrobial activity against infections caused by a variety of pathogens. These pathogens may include gram positive or negative bacteria, acid-fast bacteria such a mycobacteria, parasites, dermatophytes, or fungal pathogens. Typical fungal pathogens include Candida albicans and typical dermatophytes include Trichophyton rubrum and Trichophyton mentagrophytes. The hexapeptides of the present invention exhibit antifungal activity, antibacterial activity, desirable stability, and lack toxicity to the mammal receiving treatment.
摘要翻译：本发明包括在位置2和4处交替疏水残基（B），位置1和3处的亲水性，亲水性，带电荷的残基（X）和萘丙氨酸（NaI），脂族或芳族残基（O ），通常由式XBXBOB表示，其表现出针对由各种病原体引起的感染的抗微生物活性。这些病原体可以包括革兰氏阳性或阴性细菌，耐酸细菌如分枝杆菌，寄生虫，皮肤癣菌或真菌病原体。典型的真菌病原体包括白色念珠菌和典型的皮肤癣菌包括红色毛癣菌和引发毛癣菌。本发明的六肽对接受治疗的哺乳动物具有抗真菌活性，抗菌活性，理想的稳定性和缺乏毒性。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式